SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
US Stock Market Move | Popular Chinese concept stocks fell broadly, with VNET Group, Inc. Sponsored ADR (VNET.US) dropping nearly 3%.
US Stock Market Move | NXP Semiconductors NV (NXPI.US) falls over 3% after Citi sharply cuts its target price.
Applied Digital (APLD.US) quarterly results beat expectations but stock performance was flat; Wall Street remains bullish on growth prospects; Wells Fargo & Company raises price target to $55.
US Stock Market Move | Popular Chinese concept stocks fell broadly, with VNET Group, Inc. Sponsored ADR (VNET.US) dropping nearly 3%.
US Stock Market Move | NXP Semiconductors NV (NXPI.US) falls over 3% after Citi sharply cuts its target price.
Applied Digital (APLD.US) quarterly results beat expectations but stock performance was flat; Wall Street remains bullish on growth prospects; Wells Fargo & Company raises price target to $55.
